Tarsus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	183.64	94.82	224.95	71.66	171.33
Short-Term Investments	233.63	196.56	2.5	145.37	0.48
Cash & Short-Term Investments	417.27	291.38	227.44	217.03	171.82
Cash Growth	43.21%	28.11%	4.80%	26.31%	2.19%
Accounts Receivable	85.06	46.76	16.62	-	-
Other Receivables	2.05	1.3	1.09	3.58	0.09
Total Trade Receivables	87.11	48.06	17.71	3.58	0.09
Inventory	4.37	2.62	3.11	-	-
Other Current Assets	14.03	14.65	7.87	4.77	4.05
Total Current Assets	522.78	356.71	256.13	225.38	175.95
Net Property, Plant & Equipment	21.75	2.87	3.35	1.53	1.83
Other Intangible Assets	7.37	8.33	3.87	-	-
Long-Term Investments	3.87	3	0.63	0.37	-
Other Long-Term Assets	6.4	6.09	1.51	0.59	1.13
Total Assets	562.16	376.99	265.49	227.86	178.91
Accounts Payable	16.39	9.42	23.69	9.91	8.68
Accrued Expenses	101.53	55.37	13.25	5.52	2.8
Total Current Liabilities	135.7	80.61	36.94	15.43	11.48
Long-Term Debt	72.44	71.85	29.82	19.43	-
Other Long-Term Liabilities	10.6	-	1.75	0.1	0.7
Total Long-Term Liabilities	83.04	71.85	31.57	19.53	0.7
Total Liabilities	218.73	152.46	68.5	34.96	12.18
Common Stock	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	769.67	584.56	441.64	301.73	213.4
Accumulated Other Comprehensive Income	0.38	0.18	-0	-0.07	-
Retained Earnings	-426.63	-360.21	-244.66	-108.76	-46.67
Shareholders' Equity	343.43	224.53	196.99	192.9	166.73
Total Liabilities & Equity	562.16	376.99	265.49	227.86	178.91
Total Debt	72.44	71.85	29.82	19.43	0
Net Cash (Debt)	344.83	219.53	197.62	197.59	171.82
Net Cash Growth	57.08%	11.09%	0.02%	15.00%	2.19%
Net Cash Per Share	8.25	5.84	6.73	8.03	8.36
Book Value	343.43	224.53	196.99	192.9	166.73
Book Value Per Share	8.22	5.97	6.70	7.84	8.11
Tangible Book Value	336.06	216.21	193.12	192.9	166.73
Tangible Book Value Per Share	8.04	5.75	6.57	7.84	8.11

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q